A study to compare conventional salvage radiotherapy and individualized treatment based on results from PSMA PET/CT assessments in patients with recurrence after prostate cancer surgery
Phase 1
- Conditions
- Biochemical recurrence after prostate cancer surgeryMedDRA version: 21.0Level: PTClassification code: 10036911Term: Prostate cancer recurrent Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-504917-54-00
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 450
Inclusion Criteria
Patients previously treated for prostate cancer with radical prostatectomy and now having a biochemical recurrence (BCR) defined as: PSA >0.2 <2.0 ng/mL, and increasing measured twice., Multidisciplinary conference (MDK) decision to offer the patient salvage radiotherapy (SRT)., Signed Informed Consent
Exclusion Criteria
Previous prostate cancer with biochemical recurrence, Previous treatment with ADT after surgery, Previous pelvic radiotherapy, Patients with positive lymph nodes at surgery
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method